{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:26:27Z","timestamp":1787415987324,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejca.2026.116961","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:40:19Z","timestamp":1784763619000},"page":"116961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The European Organisation for Research and Treatment of Cancer Quality of Life Group: Past achievements and future priorities in patient-reported outcomes in oncology"],"prefix":"10.1016","volume":"245","author":[{"given":"Kelly M.","family":"de Ligt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"van der Weijst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Arraras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1864-5371","authenticated-orcid":false,"given":"Anne","family":"Bredart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-5950","authenticated-orcid":false,"given":"Johannes M.","family":"Giesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-8686","authenticated-orcid":false,"given":"Olga","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-3621","authenticated-orcid":false,"given":"Bernhard","family":"Holzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-2113","authenticated-orcid":false,"given":"Dagmara","family":"Kuli\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Oerlemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-4222","authenticated-orcid":false,"given":"Aliz\u00e9","family":"Rogge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Pe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8755-146X","authenticated-orcid":false,"given":"Samantha","family":"Sodergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7317-0858","authenticated-orcid":false,"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap C.","family":"Reijneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Sprangers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Darlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Efficace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Golfinopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens","family":"Gr\u00f8nvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Litiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kuljanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116961_bib1","series-title":"Encyclopedia of Behavioral Medicine","first-page":"929","article-title":"Health-Related Quality of Life","author":"de Wit","year":"2013"},{"key":"10.1016\/j.ejca.2026.116961_bib2","unstructured":"European Medicines Agency (EMA). EMA Regulatory Science to 2025. Strategic Reflection. 2020 [cited 2025 July 28th 2025]; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/ema-regulatory-science-2025-strategic-reflection_en.pdf."},{"key":"10.1016\/j.ejca.2026.116961_bib3","series-title":"Regulatory Decision Making","article-title":"FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient\u2019s Voice in Medical Product Development and","author":"US Food and Drug Administration","year":"2025"},{"issue":"8","key":"10.1016\/j.ejca.2026.116961_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103654","article-title":"Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology","volume":"9","author":"Paratore","year":"2024","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.ejca.2026.116961_bib5","article-title":"Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice","volume":"10","author":"Gibbons","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejca.2026.116961_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jval.2020.11.004","article-title":"Past and current practice of patient-reported outcome measurement in randomized cancer clinical trials: a systematic review","volume":"24","author":"Giesinger","year":"2021","journal-title":"Value Health"},{"issue":"Suppl 4","key":"10.1016\/j.ejca.2026.116961_bib7","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0959-8049(01)00448-8","article-title":"Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer","volume":"38","author":"Fayers","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116961_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2026.116961_bib9","doi-asserted-by":"crossref","DOI":"10.2196\/69398","article-title":"Sustainability and time trends in electronic patient-reported outcome assessment in routine cancer care: systematic scoping review and follow-up survey","volume":"27","author":"Hubel","year":"2025","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.ejca.2026.116961_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2022.10.026","article-title":"Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer","volume":"178","author":"Cocks","year":"2023","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116961_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2005.06.022","article-title":"The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care","volume":"42","author":"Groenvold","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116961_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115392","article-title":"Flexibility in patient-reported outcome and health-related quality of life measurement: the EORTC Quality of Life Group measurement strategy","volume":"220","author":"Piccinin","year":"2025","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116961_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1359-6349(12)70023-X","article-title":"Health-Related Quality of Life in EORTC clinical trials \u2014 30 years of progress from methodological developments to making a real impact on oncology practice","volume":"10","author":"Velikova","year":"2012","journal-title":"Eur J Cancer Suppl"},{"issue":"2","key":"10.1016\/j.ejca.2026.116961_bib14","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(19)30790-9","article-title":"International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium","volume":"21","author":"Coens","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116961_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.annonc.2022.12.004","article-title":"Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit","volume":"34","author":"Oosting","year":"2023","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2026.116961_bib16","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1016\/S1470-2045(25)00288-8","article-title":"Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer","volume":"26","author":"Tannock","year":"2025","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2026.116961_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2017.08.2236","article-title":"The Use of the EORTC Item Library to Supplement EORTC Quality of Life Instruments","volume":"20","author":"Kuli\u015b","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.ejca.2026.116961_bib18","unstructured":"Division of Drug Information Center for Drug Evaluation and Research, Core Patient-Reported Outcomes in Cancer Clinical Trials Guidance for Industry Oncology Center of Excellence (OCE), Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER), Editors. 2024, U.S. Department of Health and Human Services, Food and Drug Administration."},{"key":"10.1016\/j.ejca.2026.116961_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103262","article-title":"The EORTC QLQ-F17 as a shortened version of the EORTC QLQ-C30 to assess self-reported functioning in cancer patients: investigating equivalence and psychometric properties in a randomized cross-over trial","volume":"84","author":"Zeman","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"8","key":"10.1016\/j.ejca.2026.116961_bib20","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ejca.2010.02.011","article-title":"Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions \u2013 general approach and initial results for physical functioning","volume":"46","author":"Petersen","year":"2010","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2026.116961_bib21","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s11136-020-02421-9","article-title":"International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer","volume":"29","author":"Petersen","year":"2020","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.ejca.2026.116961_bib22","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s11136-023-03373-6","article-title":"Development of a diverse set of standard short forms based on the EORTC CAT Core item banks","volume":"32","author":"Petersen","year":"2023","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.ejca.2026.116961_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11764-021-01160-1","article-title":"Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire","volume":"17","author":"van Leeuwen","year":"2023","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.ejca.2026.116961_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115235","article-title":"Cancer-specific utility instrument for health economic evaluations: a synopsis of the EORTC QLU-C10D user manual and current validity evidence","volume":"217","author":"Seyringer","year":"2025","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2026.116961_bib25","first-page":"2555","article-title":"Developing an e-learning course on the use of PRO measures in oncological practice: health care professionals' preferences for learning content and methods","volume":"30","author":"Sztankay","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2026.116961_bib26","unstructured":"Rammant E., Ramsey I., de Ligt K.M., et al., Barriers and facilitators for implementing patient-reported outcome measures in oncology practices: an umbrella review. Quality Life Research, in press."},{"key":"10.1016\/j.ejca.2026.116961_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2023.04.027","article-title":"Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: a synthesis across 21 clinical trials involving nine different cancer types","volume":"188","author":"Musoro","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116961_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","article-title":"General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States","volume":"107","author":"Nolte","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116961_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejca.2018.11.023","article-title":"Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core","volume":"107","author":"Liegl","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116961_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.10.003","article-title":"Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research","volume":"118","author":"Giesinger","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejca.2026.116961_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jclinepi.2019.09.028","article-title":"Thresholds for clinical importance were defined for the European Organisation for Research and Treatment of Cancer Computer Adaptive Testing Core-an adaptive measure of core quality of life domains in oncology clinical practice and research","volume":"117","author":"Giesinger","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116961_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/jpm.2020.0159","article-title":"Evaluating the thresholds for clinical importance of the EORTC QLQ-C15-PAL in patients receiving palliative treatment","volume":"24","author":"Pilz","year":"2021","journal-title":"J Palliat Med"},{"issue":"2","key":"10.1016\/j.ejca.2026.116961_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1470-2045(25)00679-5","article-title":"Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial","volume":"27","author":"Wintner","year":"2026","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116961_bib34","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-026-04179-y","article-title":"Assessing the assessment: a scoping review of the mode of patient-reported outcome assessment in solid cancer clinical trials","volume":"35","author":"Hubel","year":"2026","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.ejca.2026.116961_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s41687-025-00907-z","article-title":"Development of a unified system for assessing health related quality of life across the cancer care continuum: the EUonQoL Delphi study to identify priorities for quality of life domains","volume":"9","author":"Sweegers","year":"2025","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.ejca.2026.116961_bib36","article-title":"Opportunities and challenges in pooling health-related quality-of-life data for prediction modeling in breast cancer across Europe: lessons from the EORTC BALANCE project","volume":"9","author":"van der Heijden","year":"2025","journal-title":"ESMO Real World Data Digit Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116961_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyag005","article-title":"Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis","volume":"31","author":"Asogwa","year":"2026","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2026.116961_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103153","article-title":"Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study","volume":"82","author":"Lim","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.ejca.2026.116961_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11136-024-03820-y","article-title":"Exploring the role of health-related quality of life measures in predictive modelling for oncology: a systematic review","volume":"34","author":"van der Heijden","year":"2025","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ejca.2026.116961_bib40","doi-asserted-by":"crossref","first-page":"S1174","DOI":"10.1016\/j.annonc.2025.08.2903","article-title":"2287MO Development of a patient involvement framework for EORTC: insights from a survey with patient partners and oncology professionals","volume":"36","author":"Shakhnenko","year":"2025","journal-title":"Ann Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T16:19:40Z","timestamp":1787415580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926007422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S0959804926007422"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116961","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The European Organisation for Research and Treatment of Cancer Quality of Life Group: Past achievements and future priorities in patient-reported outcomes in oncology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116961"}}